LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Outlook Therapeutics (NASDAQ: OTLK)

Follow NASDAQ:OTLK Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ OTLK Outlook Therapeutics
Sukhtian Ghiath M. / director, 10 percent owner:
01/17/2025
Buy
$2.26
3.46M
$7.816M
3.46M
NASDAQ OTLK Outlook Therapeutics
Sukhtian Ghiath M. / director, 10 percent owner:
01/17/2025
Buy
$2.51
3.46M
$8.681M
3.46M
NASDAQ OTLK Outlook Therapeutics
Sukhtian Ghiath M. / director, 10 percent owner:
01/17/2025
Sell
$2.51
3.46M
$8.681M
0
NASDAQ OTLK Outlook Therapeutics
Sukhtian Ghiath M. / director, 10 percent owner:
01/17/2025
Sell
$7.70
3.46M
$26.631M
0

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous